Clinical Trial Update: Project ADHERE: Clinical Proof-of-Concept of a Tenofovir (TFV) Aptamer-Based Biosensor [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial update for Project ADHERE evaluating a tenofovir aptamer-based biosensor; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids

Drugs mentioned

• Tenofovir (Tenofovir)

Snippet

Sponsor: Eastern Virginia Medical School | Conditions: HIV/AIDS, Adherence, Medication | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2024-01-30